Beam Therapeutics Inc. · NASDAQ:BEAM

Farallon Capital Management, L.L.C. reported a 9.99% stake in Beam Therapeutics Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 13, 2026

Farallon Capital Management, L.L.C. reported a 9.99% stake in Beam Therapeutics Inc., 10,282,210 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
10,282,210
Intent
Passive
What changed
Stake changed
Filed together
29 holders

The filing in full

HolderStakeShares
Farallon Capital Management, L.L.C.9.99%10,282,210
Farallon Capital Partners, L.P.0%0
Farallon Capital Institutional Partners, L.P.0%0
Farallon Capital Institutional Partners II, L.P.0%0
Farallon Capital Institutional Partners III, L.P.0%0
Four Crossings Institutional Partners V, L.P.0%0
Farallon Capital Offshore Investors II, L.P.0%0
Farallon Capital (AM) Investors, L.P.0%0
Farallon Capital F5 Master I, L.P.0%0
Farallon Healthcare Partners Master, L.P.0%0
Farallon Partners, L.L.C.0%0
Farallon Institutional (GP) V, L.L.C.0%0
Farallon F5 (GP), L.L.C.0%0
Farallon Healthcare Partners (GP), L.L.C.0%0
Dapice Joshua J.9.99%10,282,210
Dreyfuss, Philip D.9.99%10,282,210
Dunn Hannah E.9.99%10,282,210
Gehani, Varun N.9.99%10,282,210
Giauque, Nicolas9.99%10,282,210
Husen, Avner A.9.99%10,282,210
Kim, David T.9.99%10,282,210
Linn, Michael G.9.99%10,282,210
Luo Patrick (Cheng)9.99%10,282,210
Roberts, Jr., Thomas G.9.99%10,282,210
Saito Edric C.9.99%10,282,210
Short Daniel S.9.99%10,282,210
Spokes, Andrew J. M.9.99%10,282,210
Warren, John R.9.99%10,282,210
Wehrly, Mark C.9.99%10,282,210

Source

View original at SEC

Related